 | • レポートコード：D0804-09326 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、眼科用薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼科用薬の種類別市場規模（目薬、眼軟膏、ゲル化剤、錠剤、注射剤）、用途別市場規模（抗疲労・乾燥、白内障、抗感染症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novaliq、Mentholatum、Chengdu Kanghong Pharmaceutical Group、Shenyang Xingqi Pharmaceutical Co.,Ltd.、Alcon NV、Zhejiang Shapuaisi Pharmaceutical、Bausch Health、Santen Pharmaceutica ・地域別グローバル市場分析 2015年-2020年 ・眼科用薬の北米市場（アメリカ、カナダ、メキシコ） ・眼科用薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・眼科用薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・眼科用薬の南米市場（ブラジル、アルゼンチン） ・眼科用薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：目薬、眼軟膏、ゲル化剤、錠剤、注射剤 ・用途別分析：抗疲労・乾燥、白内障、抗感染症 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Ophthalmic Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Ophthalmic Medicine sales will be xx in 2020 from Ophthalmic Medicine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Ophthalmic Medicine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Ophthalmic Medicine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Ophthalmic Medicine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Ophthalmic Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ophthalmic Medicine market has been segmented into
Eye Drops
Eye Ointment
Gelling Agent
Tablet
Injection
By Application, Ophthalmic Medicine has been segmented into:
Anti-fatigue and Dryness
Cataract
Anti-infective
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ophthalmic Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Ophthalmic Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ophthalmic Medicine market.
The report offers in-depth assessment of the growth and other aspects of the Ophthalmic Medicine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ophthalmic Medicine Market Share Analysis
Ophthalmic Medicine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ophthalmic Medicine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ophthalmic Medicine sales, revenue and market share for each player covered in this report.
The major players covered in Ophthalmic Medicine are:
Novaliq
Mentholatum
Chengdu Kanghong Pharmaceutical Group
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Alcon NV
Zhejiang Shapuaisi Pharmaceutical
Bausch Health
Santen Pharmaceutica
Among other players domestic and global, Ophthalmic Medicine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmic Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ophthalmic Medicine, with price, sales, revenue and global market share of Ophthalmic Medicine in 2018 and 2019.
Chapter 3, the Ophthalmic Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ophthalmic Medicine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ophthalmic Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ophthalmic Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ophthalmic Medicine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Eye Drops
1.2.3 Eye Ointment
1.2.4 Gelling Agent
1.2.5 Tablet
1.2.6 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Ophthalmic Medicine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anti-fatigue and Dryness
1.3.3 Cataract
1.3.4 Anti-infective
1.4 Overview of Global Ophthalmic Medicine Market
1.4.1 Global Ophthalmic Medicine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Ophthalmic Medicine Industry Impact
1.6.1 COVID-19 Potential Implications for the Ophthalmic Medicine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Ophthalmic Medicine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Novaliq
2.1.1 Novaliq Details
2.1.2 Novaliq Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novaliq SWOT Analysis
2.1.4 Novaliq Product and Services
2.1.5 Novaliq Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mentholatum
2.2.1 Mentholatum Details
2.2.2 Mentholatum Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mentholatum SWOT Analysis
2.2.4 Mentholatum Product and Services
2.2.5 Mentholatum Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chengdu Kanghong Pharmaceutical Group
2.3.1 Chengdu Kanghong Pharmaceutical Group Details
2.3.2 Chengdu Kanghong Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Chengdu Kanghong Pharmaceutical Group SWOT Analysis
2.3.4 Chengdu Kanghong Pharmaceutical Group Product and Services
2.3.5 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd.
2.4.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Details
2.4.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. SWOT Analysis
2.4.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Product and Services
2.4.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alcon NV
2.5.1 Alcon NV Details
2.5.2 Alcon NV Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alcon NV SWOT Analysis
2.5.4 Alcon NV Product and Services
2.5.5 Alcon NV Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zhejiang Shapuaisi Pharmaceutical
2.6.1 Zhejiang Shapuaisi Pharmaceutical Details
2.6.2 Zhejiang Shapuaisi Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Zhejiang Shapuaisi Pharmaceutical SWOT Analysis
2.6.4 Zhejiang Shapuaisi Pharmaceutical Product and Services
2.6.5 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bausch Health
2.7.1 Bausch Health Details
2.7.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bausch Health SWOT Analysis
2.7.4 Bausch Health Product and Services
2.7.5 Bausch Health Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Santen Pharmaceutica
2.8.1 Santen Pharmaceutica Details
2.8.2 Santen Pharmaceutica Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Santen Pharmaceutica SWOT Analysis
2.8.4 Santen Pharmaceutica Product and Services
2.8.5 Santen Pharmaceutica Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ophthalmic Medicine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ophthalmic Medicine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ophthalmic Medicine Manufacturer Market Share in 2019
3.3.2 Top 6 Ophthalmic Medicine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ophthalmic Medicine Sales, Revenue and Market Share by Regions
4.1.1 Global Ophthalmic Medicine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ophthalmic Medicine Revenue and Market Share by Regions (2015-2020)
4.2 North America Ophthalmic Medicine Sales and Growth Rate (2015-2020)
4.3 Europe Ophthalmic Medicine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ophthalmic Medicine Sales and Growth Rate (2015-2020)
4.5 South America Ophthalmic Medicine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ophthalmic Medicine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ophthalmic Medicine Sales, Revenue and Market Share by Country
5.1.1 North America Ophthalmic Medicine Sales and Market Share by Country (2015-2020)
5.1.2 North America Ophthalmic Medicine Revenue and Market Share by Country (2015-2020)
5.2 United States Ophthalmic Medicine Sales and Growth Rate (2015-2020)
5.3 Canada Ophthalmic Medicine Sales and Growth Rate (2015-2020)
5.4 Mexico Ophthalmic Medicine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ophthalmic Medicine Sales, Revenue and Market Share by Country
6.1.1 Europe Ophthalmic Medicine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ophthalmic Medicine Revenue and Market Share by Country (2015-2020)
6.2 Germany Ophthalmic Medicine Sales and Growth Rate (2015-2020)
6.3 UK Ophthalmic Medicine Sales and Growth Rate (2015-2020)
6.4 France Ophthalmic Medicine Sales and Growth Rate (2015-2020)
6.5 Russia Ophthalmic Medicine Sales and Growth Rate (2015-2020)
6.6 Italy Ophthalmic Medicine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ophthalmic Medicine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ophthalmic Medicine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ophthalmic Medicine Revenue and Market Share by Regions (2015-2020)
7.2 China Ophthalmic Medicine Sales and Growth Rate (2015-2020)
7.3 Japan Ophthalmic Medicine Sales and Growth Rate (2015-2020)
7.4 Korea Ophthalmic Medicine Sales and Growth Rate (2015-2020)
7.5 India Ophthalmic Medicine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ophthalmic Medicine Sales and Growth Rate (2015-2020)
7.7 Australia Ophthalmic Medicine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ophthalmic Medicine Sales, Revenue and Market Share by Country
8.1.1 South America Ophthalmic Medicine Sales and Market Share by Country (2015-2020)
8.1.2 South America Ophthalmic Medicine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ophthalmic Medicine Sales and Growth Rate (2015-2020)
8.3 Argentina Ophthalmic Medicine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ophthalmic Medicine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ophthalmic Medicine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ophthalmic Medicine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ophthalmic Medicine Sales and Growth Rate (2015-2020)
9.3 Turkey Ophthalmic Medicine Sales and Growth Rate (2015-2020)
9.4 Egypt Ophthalmic Medicine Sales and Growth Rate (2015-2020)
9.5 South Africa Ophthalmic Medicine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ophthalmic Medicine Sales and Market Share by Type (2015-2020)
10.2 Global Ophthalmic Medicine Revenue and Market Share by Type (2015-2020)
10.3 Global Ophthalmic Medicine Price by Type (2015-2020)
11 Global Ophthalmic Medicine Market Segment by Application
11.1 Global Ophthalmic Medicine Sales Market Share by Application (2015-2020)
11.2 Global Ophthalmic Medicine Revenue Market Share by Application (2015-2020)
11.3 Global Ophthalmic Medicine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ophthalmic Medicine Sales, Revenue and Growth Rate (2021-2025)
12.2 Ophthalmic Medicine Market Forecast by Regions (2021-2025)
12.2.1 North America Ophthalmic Medicine Market Forecast (2021-2025)
12.2.2 Europe Ophthalmic Medicine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ophthalmic Medicine Market Forecast (2021-2025)
12.2.4 South America Ophthalmic Medicine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ophthalmic Medicine Market Forecast (2021-2025)
12.3 Ophthalmic Medicine Market Forecast by Type (2021-2025)
12.3.1 Global Ophthalmic Medicine Sales Forecast by Type (2021-2025)
12.3.2 Global Ophthalmic Medicine Market Share Forecast by Type (2021-2025)
12.4 Ophthalmic Medicine Market Forecast by Application (2021-2025)
12.4.1 Global Ophthalmic Medicine Sales Forecast by Application (2021-2025)
12.4.2 Global Ophthalmic Medicine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ophthalmic Medicine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ophthalmic Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ophthalmic Medicine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Ophthalmic Medicine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Novaliq Basic Information, Manufacturing Base and Competitors
Table 9. Novaliq Ophthalmic Medicine Major Business
Table 10. Novaliq Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 11. Novaliq SWOT Analysis
Table 12. Novaliq Ophthalmic Medicine Product and Services
Table 13. Novaliq Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Mentholatum Basic Information, Manufacturing Base and Competitors
Table 15. Mentholatum Ophthalmic Medicine Major Business
Table 16. Mentholatum Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 17. Mentholatum SWOT Analysis
Table 18. Mentholatum Ophthalmic Medicine Product and Services
Table 19. Mentholatum Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 21. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Major Business
Table 22. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 23. Chengdu Kanghong Pharmaceutical Group SWOT Analysis
Table 24. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product and Services
Table 25. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Shenyang Xingqi Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 27. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Major Business
Table 28. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 29. Shenyang Xingqi Pharmaceutical Co.,Ltd. SWOT Analysis
Table 30. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product and Services
Table 31. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Alcon NV Basic Information, Manufacturing Base and Competitors
Table 33. Alcon NV Ophthalmic Medicine Major Business
Table 34. Alcon NV Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 35. Alcon NV SWOT Analysis
Table 36. Alcon NV Ophthalmic Medicine Product and Services
Table 37. Alcon NV Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Zhejiang Shapuaisi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Major Business
Table 40. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 41. Zhejiang Shapuaisi Pharmaceutical SWOT Analysis
Table 42. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product and Services
Table 43. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 45. Bausch Health Ophthalmic Medicine Major Business
Table 46. Bausch Health Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 47. Bausch Health SWOT Analysis
Table 48. Bausch Health Ophthalmic Medicine Product and Services
Table 49. Bausch Health Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Santen Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 51. Santen Pharmaceutica Ophthalmic Medicine Major Business
Table 52. Santen Pharmaceutica Ophthalmic Medicine Total Revenue (USD Million) (2018-2019)
Table 53. Santen Pharmaceutica SWOT Analysis
Table 54. Santen Pharmaceutica Ophthalmic Medicine Product and Services
Table 55. Santen Pharmaceutica Ophthalmic Medicine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Ophthalmic Medicine Sales by Manufacturer (2018-2019) (K Units)
Table 57. Global Ophthalmic Medicine Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Ophthalmic Medicine Sales by Regions (2015-2020) (K Units)
Table 59. Global Ophthalmic Medicine Sales Market Share by Regions (2015-2020)
Table 60. Global Ophthalmic Medicine Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Ophthalmic Medicine Sales by Countries (2015-2020) (K Units)
Table 62. North America Ophthalmic Medicine Sales Market Share by Countries (2015-2020)
Table 63. North America Ophthalmic Medicine Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Ophthalmic Medicine Revenue Market Share by Countries (2015-2020)
Table 65. Europe Ophthalmic Medicine Sales by Countries (2015-2020) (K Units)
Table 66. Europe Ophthalmic Medicine Sales Market Share by Countries (2015-2020)
Table 67. Europe Ophthalmic Medicine Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Ophthalmic Medicine Sales by Regions (2015-2020) (K Units)
Table 69. Asia-Pacific Ophthalmic Medicine Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Ophthalmic Medicine Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Ophthalmic Medicine Sales by Countries (2015-2020) (K Units)
Table 72. South America Ophthalmic Medicine Sales Market Share by Countries (2015-2020)
Table 73. South America Ophthalmic Medicine Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Ophthalmic Medicine Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Ophthalmic Medicine Sales by Countries (2015-2020) (K Units)
Table 76. Middle East & Africa Ophthalmic Medicine Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Ophthalmic Medicine Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Countries (2015-2020)
Table 79. Global Ophthalmic Medicine Sales by Type (2015-2020) (K Units)
Table 80. Global Ophthalmic Medicine Sales Share by Type (2015-2020)
Table 81. Global Ophthalmic Medicine Revenue by Type (2015-2020) (USD Million)
Table 82. Global Ophthalmic Medicine Revenue Share by Type (2015-2020)
Table 83. Global Ophthalmic Medicine Sales by Application (2015-2020) (K Units)
Table 84. Global Ophthalmic Medicine Sales Share by Application (2015-2020)
Table 85. Global Ophthalmic Medicine Sales Forecast by Regions (2021-2025) (K Units)
Table 86. Global Ophthalmic Medicine Market Share Forecast by Regions (2021-2025)
Table 87. Global Ophthalmic Medicine Sales Forecast by Type (2021-2025) (K Units)
Table 88. Global Ophthalmic Medicine Market Share Forecast by Type (2021-2025)
Table 89. Global Ophthalmic Medicine Sales Forecast by Application (2021-2025)
Table 90. Global Ophthalmic Medicine Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ophthalmic Medicine Picture
Figure 2. Global Sales Market Share of Ophthalmic Medicine by Type in 2019
Figure 3. Eye Drops Picture
Figure 4. Eye Ointment Picture
Figure 5. Gelling Agent Picture
Figure 6. Tablet Picture
Figure 7. Injection Picture
Figure 8. Ophthalmic Medicine Sales Market Share by Application in 2018
Figure 9. Anti-fatigue and Dryness Picture
Figure 10. Cataract Picture
Figure 11. Anti-infective Picture
Figure 12. Global Ophthalmic Medicine Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Ophthalmic Medicine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Ophthalmic Medicine Sales Market Share by Manufacturer in 2019
Figure 33. Global Ophthalmic Medicine Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Ophthalmic Medicine Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Ophthalmic Medicine Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Ophthalmic Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Ophthalmic Medicine Revenue Market Share by Regions (2015-2020)
Figure 40. Global Ophthalmic Medicine Revenue Market Share by Regions in 2018
Figure 41. North America Ophthalmic Medicine Sales and Growth Rate (2015-2020)
Figure 42. Europe Ophthalmic Medicine Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Ophthalmic Medicine Sales and Growth Rate (2015-2020)
Figure 44. South America Ophthalmic Medicine Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Ophthalmic Medicine Sales and Growth Rate (2015-2020)
Figure 46. North America Ophthalmic Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Ophthalmic Medicine Sales Market Share by Countries (2015-2020)
Figure 48. North America Ophthalmic Medicine Sales Market Share by Countries in 2018
Figure 49. North America Ophthalmic Medicine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Ophthalmic Medicine Revenue Market Share by Countries in 2018
Figure 51. United States Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Ophthalmic Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Ophthalmic Medicine Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Ophthalmic Medicine Revenue Market Share by Countries in 2019
Figure 57. Germany Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Ophthalmic Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Ophthalmic Medicine Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Ophthalmic Medicine Revenue Market Share by Regions 2019
Figure 65. China Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Ophthalmic Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Ophthalmic Medicine Sales Market Share by Countries in 2019
Figure 72. South America Ophthalmic Medicine Revenue Market Share by Countries in 2019
Figure 73. Brazil Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Ophthalmic Medicine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Ophthalmic Medicine Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Ophthalmic Medicine Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Ophthalmic Medicine Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Ophthalmic Medicine Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Ophthalmic Medicine Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Ophthalmic Medicine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Ophthalmic Medicine Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Ophthalmic Medicine Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Ophthalmic Medicine Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Ophthalmic Medicine Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Ophthalmic Medicine Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
眼科用デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmic Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 41210 million by 2025, from USD 38060 million in 2019. The Ophthalmic Devices …- 眼科用デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmic Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 41210 million by 2025, from USD 38060 million in 2019. The Ophthalmic Devices …
- 眼科手術器具（OVD）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmic Viscosurgical Devices (OVD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophtha…
- 獣医用検査製品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Veterinary Ophthalmic Examination Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ve…
- 眼科用フックの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmic Hooks market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmic Hooks market repo…